Kautilya

New Drug for Coronary Diseases Could be in Offing

Council of Scientific and Industrial Research (CSIR)’s Lucknow-based constituent laboratory Central Drug Research Institute (CDRI) and Marc Laboratories Ltd, India have come together to develop a new safer drug for heart attack and stroke. They have signed the license agreement for developing drug for coronary and cerebral artery diseases.

Researchers Find An Improved Method of Imaging Objects Through Fog

Research by a team has offered a solution for improving the image quality without heavy computations. The team from the Raman Research Institute (RRI), Bengaluru, an autonomous institute of the Department of Science and Technology; Space Applications Centre, Indian Space Research Organisation, Ahmedabad; Shiv Nadar University, Gautam Buddha Nagar; and Université Rennes and Université Paris-Saclay, CNRS, France, modulated the light source and demodulated them at the observer’s end to achieve sharper images. The research was published in the journal ‘OSA Continuum’.

Patients May Experience Post-COVID Symptoms Up to 3-6 Months After Recover

Dr. Nikhil Narayan Bante, Lungs and TB Specialist, pointed out that a large number of COVID recovered patients are facing post-COVID-19 syndromes in the second wave of the pandemic. “Around 50%-70% of patients may experience minor or even major symptoms up to 3-6 months after recovering from COVID-19 and is observed more in those patients who had moderate or severe form of the infection”, he added

Paytm Launches Vaccine Appointment Booking Feature on Mobile App

Paytm said, “Paytm users can now explore, find and book the available vaccination slots for both Covaxin and Covishield vaccines at the nearby centre via the Paytm app. The feature would benefit Indians effortlessly book vaccination slots and gain immunity, assisting in combating the ongoing pandemic.”